Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Approvable Letter Received for Covera-hs(tm) SKOKIE, Ill., Jan. 29, 1996 -- G.D. Searle & Co.. and ALZA Corporation (NYSE: AZA) today announced that the U.S. Food and Drug Administration (FDA) has issued to Searle an approvable letter for the marketing of Covera-HS(TM) (verapamil), a once-daily controlled release calcium channel blocker for the treatment of hypertension and angina. Final FDA approval is subject to satisfaction of the conditions specified in the approvable letter. Covera-HS incorporates ALZA's controlled onset, extended release delivery system. Taken at bedtime, the product is designed to deliver peak concentrations of drug in the early morning hours. Upon final marketing clearance from the FDA, Covera-HS will be marketed by Searle and manufactured by ALZA, and ALZA will receive royalties based on sales of the product. ALZA Corporation, headquartered in Palo Alto, Calif., is a leader in the development and commercialization of innovative pharmaceutical products using advanced drug delivery technologies to add medical and economic value to drug therapies. Searle, a wholly-owned subsidiary of Monsanto Company (NYSE: MTC), is a research-based corporation that develops, manufactures and markets pharmaceutical products and other health care solutions worldwide. CONTACT: Kristin R. Fayer of Searle, 847-470-6728; or Michael Boennighausen of ALZA, 415-494-5222 (AZA MTC) E-mail this page to a friend or colleague! To print, use this version